Raymond James Initiates Actavis With Outperform

Raymond James initiated coverage on

with a Outperform rating. The target price for Actavis is set to $344. Actavis shares have gained 42.00 percent over the past 52 weeks, while the S&P 500 index has surged 9.43 percent in the same period. Actavis' shares closed at $305.66 yesterday.